What Does Vor Biopharma Do?

Total employees100
HeadquartersCambridge
Founded2015

Vor Biopharma (Nasdaq: VOR) is a clinical-stage cell and genome engineering company that is pioneering a novel approach to targeted cancer therapy. Their mission is to develop innovative treatments for patients with hematological malignancies by engineering hematopoietic stem cells (HSCs) to be treatment-resistant, thereby enabling more potent and effective targeted therapies. Vor Bio's lead product candidate, trem-cel (VOR33), consists of genome-edited HSCs that lack CD33, a protein commonly expressed on leukemia cells. This allows for targeted anti-CD33 therapies to be used post-transplant without harming the healthy new blood system. The company is leveraging its scientific expertise in HSC biology and genome editing to create a new paradigm in cancer care.

Where Is Vor Biopharma's Headquarters?

Vor Biopharma officeVor Biopharma officeVor Biopharma officeVor Biopharma office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for research and development, clinical operations, corporate strategy, and administrative functions.

Notable Features:

State-of-the-art laboratory facilities for advanced cell and genome engineering research, designed to support cutting-edge scientific discovery and process development. Proximity to world-class research institutions and a vibrant biotech talent pool.

Work Culture:

A dynamic, collaborative, and patient-focused environment. The culture emphasizes scientific rigor, innovation, teamwork, and a shared commitment to developing transformative therapies for cancer patients. Employees are driven by a strong sense of purpose and the potential to make a significant impact.

HQ Significance:

The Cambridge headquarters is crucial for Vor Biopharma's operations, providing access to a rich ecosystem of scientific talent, research collaborations, and industry partners. It centralizes their R&D efforts and strategic decision-making.

Values Reflected in HQ: The headquarters' location and design reflect Vor Biopharma's commitment to innovation, scientific excellence, and collaboration. Being in a leading biotech hub facilitates access to cutting-edge research and talent, while the modern facilities support their pioneering work.

Location:

While primarily based in the United States with its research and corporate hub in Cambridge, MA, Vor Biopharma's impact is global. The company engages in international clinical trials to evaluate its novel therapies, collaborates with research institutions and partners worldwide, and aims to bring its innovative treatments to cancer patients globally. Its strategic partnerships and clinical activities extend its operational reach beyond its physical locations.

Street Address:

100 Cambridgepark Drive, Suite 400

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Vor Biopharma Operate Around the World?

Cambridge, MA/USA

Address: 300 Cambridgepark Drive, Cambridge, MA 02140, USA

Expansion of R&D and operational capacity within the Cambridge biotech cluster, allowing for specialized functions and growth.

Buying Intent Signals for Vor Biopharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Vor Biopharma? Meet the Executive Team

As of April 2025, Vor Biopharma' leadership includes:

Robert Ang, MBBS - President and Chief Executive Officer
Eyal C. Attar, M.D. - Chief Medical Officer
Tirtha Chakraborty, Ph.D. - Chief Scientific Officer
Nathan Jorgensen, Ph.D., MBA - Chief Financial Officer
Matthew R. Patricelli, J.D., Ph.D. - Chief Operating Officer and General Counsel

Who's Investing in Vor Biopharma?

Vor Biopharma has been backed by several prominent investors over the years, including:

RA Capital Management
5AM Ventures
PureTech Health
Johnson & Johnson Innovation – JJDC, Inc.
Perceptive Advisors
F-Prime Capital
Fidelity Management & Research Company LLC
Invus
Redmile Group
TPG's The Rise Fund

What Leadership Changes Has Vor Biopharma Seen Recently?

Hire1
Exits1

In the past 12 months, Vor Biopharma strengthened its executive leadership with a key appointment in the clinical development area, following a transition in the Chief Medical Officer role.

Departures

Brent R. Warner, M.D., Ph.D., Dr. Brent R. Warner departed from his role as Chief Medical Officer.

New Appointments:

Eyal C. Attar, M.D., Dr. Eyal C. Attar was appointed as Chief Medical Officer to lead clinical strategy and development.

What Technology (Tech Stack) Is Used byVor Biopharma?

Discover the tools Vor Biopharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Vor Biopharma Email Formats and Examples

Vor Biopharma commonly uses the first initial followed by the last name for their email addresses. This is a frequent pattern in many biotech and pharmaceutical companies.

[first_initial][last]@vorbio.com

Format

jdoe@vorbio.com

Example

85%

Success rate

What's the Latest News About Vor Biopharma?

GlobeNewswire • May 9, 2024

Vor Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Vor Biopharma announced its financial results for the first quarter of 2024 and provided updates on its clinical programs, including progress on trem-cel (VOR33) and VCAR33ALLO programs....more

GlobeNewswire • April 2, 2024

Vor Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

Vor Biopharma announced its participation and presentation at the 23rd Annual Needham Virtual Healthcare Conference, discussing its pipeline and corporate strategy....more

GlobeNewswire • March 5, 2024

Vor Bio Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Vor Biopharma reported its fourth quarter and full year 2023 financial results, along with a comprehensive update on its research and development activities and upcoming milestones....more

GlobeNewswire • June 20, 2023

Vor Bio Appoints Eyal C. Attar, M.D., as Chief Medical Officer

Vor Biopharma announced the appointment of Eyal C. Attar, M.D., as its Chief Medical Officer, bringing extensive experience in oncology and hematology clinical development to the company....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Vor Biopharma, are just a search away.